Authors: Neuforth, Hargrave, and Markham
Parvulet® Technology is a patented oral dosage form capable of being dispensed to patients in tablet or powder formats, and converted into a semi-solid at the time of dosage through activation with water.
The final dosage is easily administered, as a soft food like texture, ideal for pediatric and geriatric populations (including those with dysphagia). The Parvulet® technology can be combined with our taste-masking and controlled release technologies, providing greater flexibility in advancing patient centric solutions.
